Indoco Remedies Limited — Important, 24-10-2024: Financial Result Updates

Indoco Remedies Limited's Board approved Q2 FY2024 financial results, reporting revenues of ₹3,946 million, down from ₹4,652 million year-over-year. EBITDA margins decreased to 13.4%, while Profit After Tax fell to ₹128 million (3.2% of sales). Challenges in the International Formulation business due to supply constraints were noted, although domestic performance remained strong. The company's ongoing focus on expanding its global footprint includes leveraging a robust R&D infrastructure and regulatory compliance.